Why Do Genes and Mutations Matter in SARS-CoV-2?

Why should we concern ourselves with genetics and mutations in SARS-CoV-2? There are many reasons why these are of interest, including the rate at which mutations are occurring. One reason is that mutations can result in immune evasion. Changes can occur in recognition sites (epitopes) for antibodies and for cytotoxic T cells, and these could,…

Read More

GVN Center and Member Spotlight – Florian Krammer

Members > Spotlights > Florian Krammer GVN Center and Member Spotlight Florian Krammer Mount Sinai Professor in Vaccinology Department of Microbiology at the Icahn School of Medicine at Mount Sinai, New York   What are you and your institution currently working on regarding SARS-CoV-2? Mount Sinai has spearheaded serological testing which was used to screen…

Read More

So Will and When Will We Have a Vaccine?

Just to cut to the chase, we just do not know; but we may hope for one year and a half to two years, maybe less. And that will be great, but we have to distinguish between getting early evidence of efficacy and getting a vaccine ready for mass vaccination. But let’s consider background material…

Read More

Testing for SARS-COV-2

Testing, Testing, Testing… The uncertainties about SARS-CoV-2 include critical questions such as what the death rate is for infected people, and what the infection rate is for the general public. This makes testing for infection of critical importance. There are numerous ways to establish the presence of infection. One is recovery of live virus, which…

Read More

GVN Center and Member Spotlight – Richard Scheuermann

Members > Spotlights > Richard Scheuermann GVN Center and Member Spotlight Richard Scheuermann Director, La Jolla Campus Craig Venter Institute   What are you and your institution currently working on regarding SARS-CoV-2?  Dr. Scheuermann is leading a team of investigators at JCVI in response to the COVID-19 outbreak.  Through his NIH-sponsored Bioinformatics Resource Center project,…

Read More

GVN Center and Member Spotlight – Linfa Wang

Members > Spotlights > Linfa Wang GVN Center and Member Spotlight Linfa Wang Professor Director of the Program in Emerging Infectious Diseases Duke-NUS Medical School, Singapore Comparing with other countries, Singapore has a relatively low infection rate of COVID-19. What can Singapore teach the U.S. and the rest of the world about responding to COVID-19?…

Read More